DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. - Wikidata - wikimedia - TriplyDB

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

http://www.wikidata.org/entity/Q37031293

about

MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment MicroRNAs in multiple myeloma and related bone disease The role of miR-29b in cancer: regulation, function, and signaling The two faces of miR-29 Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune Novel therapeutic strategies for multiple myeloma Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer.Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro MicroRNA: important player in the pathobiology of multiple myeloma Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.Crosstalk between microRNA30a/b/c/d/e-5p and the canonical Wnt pathway: implications for multiple myeloma therapy miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients.Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma.DNA modifications and neurological disorders.DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.Aberrant microRNA expression in multiple myeloma.Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.Immunologic microenvironment and personalized treatment in multiple myeloma.Perspectives in the treatment of multiple myeloma.Emerging pathways as individualized therapeutic target of multiple myeloma.Genomic instability in multiple myeloma: mechanisms and therapeutic implications.The role of epigenetics in the biology of multiple myeloma.Recent advances in the involvement of long non-coding RNAs in neural stem cell biology and brain pathophysiology.microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.MicroRNAs: New therapeutic targets for intestinal barrier dysfunction.MicroRNAs as regulators of bone homeostasis and bone metastasis.Mir-34: a new weapon against cancer?miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.

P2860

Q26765477-BD625ECD-E1F0-4C60-8880-9F73A1B31A40 Q26770478-88A5D96E-AF84-433D-BE82-783037545C71 Q26851543-3306F45E-DC66-4F11-A9F1-11ADCC121F71 Q26996481-6CE82AD1-FC94-458D-A869-297E88303540 Q26999187-7601A7E7-C873-4916-9920-3A43130131DB Q27013740-5ED3FE38-4F96-4212-BB66-59D71AADAB43 Q28081590-937C86C3-3E9A-46AD-84CB-E2A45EABFF73 Q33576891-92240A6E-23A1-4FC0-AAFC-0BF82B25E743 Q33727889-5AC85AF2-8EEC-41BC-86CE-650CFDF1102E Q33786861-8ED3952D-5686-4A7C-A2B6-E0FBC790161A Q33917555-2F11F4B5-B339-40DD-AE0D-DA41C17B16CB Q34103347-45D12671-5858-4F66-99D5-976E499229BB Q34287900-A1D1C839-E149-4DC6-A535-D71560669063 Q35023269-E0857805-CAF5-41C5-A4F8-EAAD4F464C78 Q35108549-C354150F-B85E-4B37-A44D-2603C03C1282 Q35191816-7C1A6330-E2B4-4FB9-853F-EDD4F94B6BD5 Q35742519-983EC66A-A461-47AD-A00B-427A79F07BDC Q35955440-E0548D15-B86C-4479-89FD-0F013323F2C4 Q36254566-5CB8D146-8372-4E67-BB5A-97E635B49A30 Q36413501-41A81542-E441-4C78-9E1A-32D7035BBC14 Q36642951-947754A6-722F-4CA8-A832-D621F19BAFE7 Q36860835-F956CB71-65FC-4443-8565-2A1854F581F0 Q37016562-2C54A0A7-B999-4FFF-B77F-F27995629EED Q37249117-38AD77CD-6589-4D1C-BA45-DCA70D7F2D8E Q37505517-01B1F631-77D2-49E3-8AD6-2C9CF85F48A4 Q37597751-72C5DE41-88F4-44ED-BA41-2E69785A4A26 Q38099048-4C736B76-4310-4C16-A7D2-D6EE20836C3F Q38108387-483A41D7-08A9-429A-B937-9A9AD2032EA4 Q38108390-F2A39BCA-82C5-4739-A655-317042F7F3C4 Q38108391-8CEBCBE2-CCD5-4FC4-BBDC-32E6C775D6DD Q38112176-A260157D-DEC6-45E9-A65C-DABB5C6BDB21 Q38115576-31F34F20-369E-49CA-B78F-B39BA9431B0E Q38208520-DF342801-5764-4CF7-9B31-098C94D8F2FC Q38209316-083C33A6-D2DB-4798-8B45-E2A4CFB3AAE8 Q38213075-CFC5DA24-F797-4C8A-83A4-2DA730802FD2 Q38219024-F04A870D-473C-497A-9058-F7D050A1D3A7 Q38239679-517FB5F2-E11E-4787-9427-4A6640F07FEF Q38253374-27DF9927-A535-4E34-BD31-7F06E0020BC9 Q38264923-4F2AD1AD-8C52-4EC5-96A9-ACA7AA2C826C Q38299932-19558D96-DC31-4838-96D5-FBFB6336D776

P2860

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

http://www.wikidata.org/entity/Q37031293

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

DNA-demethylating and anti-tum ...... 9b mimics in multiple myeloma.

@en

DNA-demethylating and anti-tum ...... 9b mimics in multiple myeloma.

@nl

type

label

DNA-demethylating and anti-tum ...... 9b mimics in multiple myeloma.

@en

DNA-demethylating and anti-tum ...... 9b mimics in multiple myeloma.

@nl

prefLabel

DNA-demethylating and anti-tum ...... 9b mimics in multiple myeloma.

@en

DNA-demethylating and anti-tum ...... 9b mimics in multiple myeloma.

@nl

P1433

Q37031293-DF63A709-D6D7-424E-8453-5B8E0A07BDD1

P1476

Q37031293-38A30F4D-6B98-41BC-BB7B-2DDBD56721C8

P2093

Q37031293-1D0AF9C2-49A9-421E-B392-911710AD7E0E

Q37031293-2EADEBEE-3BE6-4CA8-BEB2-B8FF816A55D8

Q37031293-4131D759-2E95-4A83-90A8-43D1199B5E8A

Q37031293-496DE988-2712-42AC-BBDA-F29C094B68A0

Q37031293-5E781269-768C-4E47-B4B4-47F239EAC1B8

Q37031293-62357D41-4877-404F-89BF-A8E843A14DBC

Q37031293-96D4C13B-BAF6-4163-ACA1-DC674E758982

Q37031293-A4429D4E-4FF2-4774-9534-C0094B83CC2B

Q37031293-D5625442-BC31-4038-92F5-A66AEF70BDA8

Q37031293-E21C785D-86C7-48EE-9DC8-C2C68D30F7A2

P2860

Q37031293-01B331DB-8EDC-4E20-BF90-552DB3F22464

Q37031293-0559FE7C-41F1-4C3D-A583-53121F1900CC

Q37031293-163B57C6-9AA2-48A1-B10D-B4EA074F11EC

Q37031293-16F8065C-F9E7-4A2B-BD9E-32685F613D0D

Q37031293-1B89EDE3-2847-4969-B3DF-078902D2046E

Q37031293-1E5BD17C-6133-4B96-835E-AC5A9E786CEA

Q37031293-1F588959-7AEC-4533-954C-40394EC9329C

Q37031293-2193AD69-4E24-4D0B-9803-474A9D48835A

Q37031293-2A3788C7-E22B-4AB9-B805-6D87E41F69B1

Q37031293-2A96D836-98E0-4044-943F-851F5243CB9B

P304

Q37031293-EF83AF2B-330E-47E4-ACD2-D9D66046DE77

P31

Q37031293-B0453438-B0CF-4A4C-9F49-A57DA9D5B6B4

P356

Q37031293-639AD06E-1AF7-4ECD-8AED-0F3607108E7F

P407

Q37031293-67B033C2-B113-4D51-A0A8-4D488F1762C9

P433

Q37031293-91C893A1-5F27-413B-A44C-0A91B92CD537

P478

Q37031293-3A6DD611-AB75-4784-91B0-1CD193608E2C

P50

Q37031293-0C2AD41F-6DE0-4FA7-ACFE-64DF78C4CBF0

Q37031293-2C60ABCD-9766-4F60-A4E8-AD9DF27CEB98

Q37031293-F365CB08-49F4-422A-95CB-A40AB18FD5DD

Q37031293-FD4136E9-3A14-463D-A342-241CF4CE05F7

P577

Q37031293-1F595B97-42CC-4005-8454-9A18071E4119

P5875

Q37031293-B1240CA7-7778-4C2A-970E-9954C9DA718F

P698

Q37031293-E2C470B7-9CDE-4597-B0CC-674D352E3CE3

P932

Q37031293-B0D1A220-F099-4844-84C6-D42F88EAF17D

P356

P1433

P1476

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma

@en

P2093

Anna Maria Gullà

http://www.w3.org/2001/XMLSchema#string

Antonio Giordano

http://www.w3.org/2001/XMLSchema#string

Dina Bellizzi

http://www.w3.org/2001/XMLSchema#string

Emanuela Leone

http://www.w3.org/2001/XMLSchema#string

Fernanda Fabiani

http://www.w3.org/2001/XMLSchema#string

Giuseppe Passarino

http://www.w3.org/2001/XMLSchema#string

Marta Lionetti

http://www.w3.org/2001/XMLSchema#string

Marzia Leotta

http://www.w3.org/2001/XMLSchema#string

Nicola Amodio

http://www.w3.org/2001/XMLSchema#string

Patrizia D'Aquila

http://www.w3.org/2001/XMLSchema#string

P2860

Role of DNA 5-methylcytosine transferase in cell transformation by fos

The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.

Prediction of mammalian microRNA targets

Combinatorial microRNA target predictions

The fundamental role of epigenetic events in cancer

MicroRNAs: genomics, biogenesis, mechanism, and function

P304

1246-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.675

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michele Caraglia

Massimo Negrini

Maria Teresa Di Martino

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232705935

http://www.w3.org/2001/XMLSchema#string

P698

23100393

http://www.w3.org/2001/XMLSchema#string

P932

3717964

http://www.w3.org/2001/XMLSchema#string